N/A N=11 Exercise Training in Heart Failure: Changes in Cardiac Structure and Function
Heart Failure
Primary: Change in Left Ventricular Systolic Function. — .82; -1.90 percent LVEF — p=.14
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=90 Exercise Training and Glucose Metabolism in Aging
Type 2 Diabetes Mellitus · Impaired Glucose Tolerance (Prediabetes)
Primary: Baseline Glucose Utilization — 0.0062; 0.0035 µmol/kgFFM/pmol insulin/min
N/A N=14 Effects of Exercise Training on Fluid Instability in Heart Failure Patients
Heart Failure
Primary: Bioelectrical Impedance Change — 47.52; 47.1; 41.27; 46.8 Percentage of Extra Cellular Fluid
N/A N=45 Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit
Heart Failure
Primary: Oxygen Uptake (VO2) Peak — 1778.1; 1228.2; 1393.7; 1763.6 ML/KG/Min
Early Phase 1 N=40 Exercise Training Effects on Metabolic Syndrome: Interactions With Medication
Exercise Therapy · Metabolic Syndrome X · Cardiorespiratory Fitness
Primary: Systolic Blood Pressure — 126; 134; 124; 133 mmHg — p=0.040
N/A N=60 Exercise Training to Improve Cognitive Function
Mild Cognitive Impairment
Primary: Change in Delayed Recall Score on Wechsler Logical Memory Task From Baseline to 6 Months — 0.74; -0.87 units on a scale
N/A N=62 Exercise Training Following Cardiac Resynchronization Therapy in Patients With Chronic Heart Failure
Cardiac Resynchronization Therapy · Chronic Heart Failure
Primary: Changes in a Composite Measure of Clinical Status - New York Heart Association Functional Class — -1.52; -1.0 scores on a scale
N/A N=88 Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)
Heart Failure, Diastolic · Obesity
Primary: Peak Exercise Oxygen Consumption (VO2) — 1609; 1653 ml/min — p=0.21
N/A N=36 Exercise Training in Asthma Children
Asthma
Primary: Exhaled Nitric Oxide (FeNO) Level — 29.3; 23.3 ppb
N/A N=30 Exercise Training for the Treatment of Generalized Anxiety Disorder
Generalized Anxiety Disorder
Primary: Generalized Anxiety Disorder (GAD) Remission as Measured by Anxiety Disorders Interview Schedule-Adult Version (ADIS-IV) Severity Ratings — 4; 6; 7 Participants
N/A N=136 Study of Exercise Training in Hypertrophic Cardiomyopathy
Cardiomyopathy, Hypertrophic
Primary: Change in Peak Oxygen Consumption (Peak VO2) — 1.35; 0.08 mL/kg/min
N/A N=90 Lung Cancer Exercise Training Study
Lung Cancer
Primary: Changes in VO2peak (on Exercise Capacity) — 17.9; 15.2; 15.2; 14.5 mL/kg/min
N/A N=45 Aerobic Training and Non-Exercise Physical Activity
Central Obesity · Obesity
Primary: Change in Waist Circumference — -1.3; -1.9; -4.1 cm — p=0.074
N/A N=16 Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure
Heart Failure NYHA Class II · Heart Failure NYHA Class III
Primary: Change From Baseline in Mean Minnesota Living With Heart Failure Questionnaire Score — 36; 57.6; 18.6; -20.6 score on a scale
N/A N=32 Physical Training and Heart Rate Variability in COPD
Chronic Obstructive Pulmonary Disease (COPD)
Primary: The SD1 Index, a Nonlinear Index of Heart Rate Variability (HRV)That Represents the Parassimpatetic Activity. — 3.7; 2.8; 7.1; 2.5 miliseconds
N/A N=100 Exercise Intolerance in Elderly Patients With Diastolic Heart Failure
Heart Failure, Diastolic · Obesity
Primary: Exercise Capacity — 15.5; 15.5; 14.1; 16.6 ml/kg/min — p=<0.001
N/A N=39 Exercise Training and Cognitive Function in Kidney Disease
Cognitive Function, Preclinical · Chronic Kidney Diseases · Older Adults
Primary: Composite Global Cognitive Function — .15; .02 Z-score
N/A N=11 Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals With Insulin Resistance
Insulin Resistance
Primary: Insulin Sensitivity After 5-7 Days of Exercise — 3; 2.5 index score — p=<0.05
Phase 3 N=34 Strength Training in Walking Tolerance in Intermittent Claudication Patients
Peripheral Arterial Disease · Hypertension · Diabetes
Primary: Total Walking Distance — 618; 572 meter — p=<0.05
N/A N=33 Strength Training and Endurance Exercise for LIFE
HIV
Primary: Aerobic Capacity — 0.15; 0.02 Liters/minute
N/A N=52 Effects of Exercise Training Intensity on Fitness and Insulin Sensitivity in African Americans
Obesity · Insulin Resistance · Sedentary Lifestyle
Primary: Change in Cardiorespiratory Fitness — -0.15; 0.12; 0.22 Liters of oxygen/min — p=0.006
N/A N=20 Sex Differences in Vascular Responses to Exercise
Aging
Primary: Change in FMD in Response to Chronic HIIT — 0.11; 0.57; 0.81; 0.10 % flow mediated dilation
N/A N=66 Study of the Long-term Effects of Exercise on Heath Indicators in Older People
Hypertension With Complications and Secondary Hypertension · Overweight and Obesity · Lipid Metabolism Disorders
Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants
N/A N=14 Isoenergetic High Intensity Interval Training and Moderate Intensity Training in Adults With Type I Diabetes
Diabetes Mellitus, Type 1
Primary: Mean Energy Expenditure Between HIIT and MICT — 264.5; 225.5 kcal — p=0.010
N/A N=119 Exercise for Brain Health in the Fight Against Alzheimer's Disease
Healthy Cognition
Primary: Rey Auditory Verbal Learning Test Sum of Trials 1-5 — 49.7; 47.6; 51.6; 49.4 Sum of words recalled Trials 1 to 5
Phase 2 N=92 Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF) (INABLE-Training)
Heart Failure
Primary: Change in Peak Rate of Oxygen (VO2) — 0.85; 0.70 ml/min/kg — p=0.770
N/A N=78 Aerobic Exercise and Cognitive Training in Older Adults
Sedentary Lifestyle
Primary: Change Executive Language Functions (Category Verbal Fluency) — 5; -1 Number of Fluent Words within 60 seconds
N/A N=75 Understanding the Exercise-Hypertension Paradox
Hypertension
Primary: Blood Pressure — 103; 106; 94; 101 mmHg
N/A N=21 Physical Training and the Incretin Effect
Healthy
Primary: Incretin Effect (the % of Insulin Secreted Due to the Release of the Intestinal Hormones Glucagon Like Peptide-1 (GLP-1 and Glucose-dependent Insulinotropic Peptide…
N/A N=80 Improving Metabolic Health in Patients With Diastolic Dysfunction
Obesity · Heart Failure, Diastolic · Metabolic Syndrome
Primary: Change From Baseline at 1 Year in Myocardial Lipid Content — -0.16; -0.18; -0.53; -0.19 %fat/water